The present study aimed to assess the changes in blood factors and ultrasound measures of atherosclerosis burden patient with mild cognitive impairment (MCI) and dementia. Peripheral blood samples and ultrasonography findings were obtained for 53 enrolled participants. Flow cytometry was used to evaluate levels of activated platelets and platelet-leukocyte aggregates (PLAs). The number of platelets expressing p-selectin was correlated with intima media thickness (IMT) and plaque number in both the MCI and dementia groups. The number of platelets expressing p-selectin glycoprotein ligand (PSGL) was strongly correlated with IMT in patients with MCI, whereas the number of platelets expressing PGSL was correlated with plaque number rather than ...
Context: Patients affected by sporadic Alzheimer disease (AD) show a significant alteration of amylo...
Objectives: A case-control study was conducted to find the prevalence of abnormal blood i...
The protracted accumulation of amyloid-β (Aβ) is a major pathologic hallmark of Alzheimer's disease ...
The present study aimed to assess the changes in blood factors and ultrasound measures of atheroscle...
Hemostasis and thrombosis may be important contributors to cognitive decline and dementia. Certain b...
Dementia is a disorder characterized by a significant decline from baseline in one or more cognitive...
Aims: To investigate the contribution of vascular risk factors (VRFs), vascular diseases (VDs) and w...
OBJECTIVE: To investigate whether midlife atherosclerosis is associated with different dementia subt...
Objective-Hemostasis and inflammation have been implicated in dementia. This study investigates the ...
Brain changes related to Alzheimer’s disease (AD) exist years before manifestation of any cognitive ...
Our aim in this study was to assess the relationship between the state of cerebral vessels and the r...
BACKGROUND: Alteration of the amyloid precursor protein (APP) forms ratio has been described in the ...
Aim of the study was to explore the correlation between the progression of carotid atherosclerosis a...
Background: Dementia is a growing challenge, and there is no curative treatment available. The most ...
The general objective of this thesis was to investigate new (quantitative) MR techniques and MR mark...
Context: Patients affected by sporadic Alzheimer disease (AD) show a significant alteration of amylo...
Objectives: A case-control study was conducted to find the prevalence of abnormal blood i...
The protracted accumulation of amyloid-β (Aβ) is a major pathologic hallmark of Alzheimer's disease ...
The present study aimed to assess the changes in blood factors and ultrasound measures of atheroscle...
Hemostasis and thrombosis may be important contributors to cognitive decline and dementia. Certain b...
Dementia is a disorder characterized by a significant decline from baseline in one or more cognitive...
Aims: To investigate the contribution of vascular risk factors (VRFs), vascular diseases (VDs) and w...
OBJECTIVE: To investigate whether midlife atherosclerosis is associated with different dementia subt...
Objective-Hemostasis and inflammation have been implicated in dementia. This study investigates the ...
Brain changes related to Alzheimer’s disease (AD) exist years before manifestation of any cognitive ...
Our aim in this study was to assess the relationship between the state of cerebral vessels and the r...
BACKGROUND: Alteration of the amyloid precursor protein (APP) forms ratio has been described in the ...
Aim of the study was to explore the correlation between the progression of carotid atherosclerosis a...
Background: Dementia is a growing challenge, and there is no curative treatment available. The most ...
The general objective of this thesis was to investigate new (quantitative) MR techniques and MR mark...
Context: Patients affected by sporadic Alzheimer disease (AD) show a significant alteration of amylo...
Objectives: A case-control study was conducted to find the prevalence of abnormal blood i...
The protracted accumulation of amyloid-β (Aβ) is a major pathologic hallmark of Alzheimer's disease ...